FOXC2 vital to epithelial-mesenchymal transition in breast cancer

[News]

Researchers have identified a pivotal protein in a cellular transformation that makes a cancer cell more resistant to treatment and more capable of growing and spreading, making it an inviting new target for drug development.

More... (http://www.news-medical.net/news/20130214/FOXC2-vital-to-epithelial-mesenchymal-transition-in-breast-cancer.aspx)